📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies (2021)

First Author: Fielding C

Attributed to: Systematic characterisation of the HCMV pathogenicity domain spontaneously lost from commonly used passaged strains funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.06.438630

Publication URI: http://dx.doi.org/10.1101/2021.04.06.438630

Type: Preprint